Despite increasing awareness of the negative health outcomes associated with obesity, the prevalence of obesity continues to increase both in the US and globally. Recent breakthroughs in the development and approval of novel anti-obesity drugs hold much promise and have reinvigorated this field. In this whitepaper, Medpace experts describe some of the key elements of study design and how these can be optimized to achieve successful study execution, with particular emphasis on managing rapid enrollment and maximizing patient retention in clinical trials. 

Download this whitepaper to gain insights into: 

• Key considerations for primary and secondary endpoint selection in obesity clinical trials 
• Strategies for managing rapid enrollment 
• Effective techniques in minimizing patient drop-out, while addressing: 
  • Perceived effect or its absence 
  • Tolerability of diet and lifestyle interventions 
  • Access to alternative treatment options